Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK500686PMID: 29999745
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 372151-71-8
Drug Levels and Effects
Summary of Use during Lactation
Telavancin is 93% plasma protein bound and is poorly absorbed orally, so it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. If telavancin is required by the mother, it is not a reason to discontinue breastfeeding. Monitor the infant for possible effects on the gastrointestinal tract, such as diarrhea, vomiting, and candidiasis (e.g., thrush, diaper rash).
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Clindamycin, Daptomycin, Doxycycline, Trimethoprim-Sulfamethoxazole, Vancomycin
Substance Identification
Substance Name
Telavancin
CAS Registry Number
372151-71-8
Drug Class
Breast Feeding
Anti-Infective Agents
Antibacterial Agents
Glycopeptides
Lipoglycopeptides
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Oritavancin.[Drugs and Lactation Database (...]Review Oritavancin.. Drugs and Lactation Database (LactMed®). 2006
- Review Dalbavancin.[Drugs and Lactation Database (...]Review Dalbavancin.. Drugs and Lactation Database (LactMed®). 2006
- Review Clindamycin.[Drugs and Lactation Database (...]Review Clindamycin.. Drugs and Lactation Database (LactMed®). 2006
- Review Omadacycline.[Drugs and Lactation Database (...]Review Omadacycline.. Drugs and Lactation Database (LactMed®). 2006
- Review Kanamycin.[Drugs and Lactation Database (...]Review Kanamycin.. Drugs and Lactation Database (LactMed®). 2006
- Telavancin - Drugs and Lactation Database (LactMed®)Telavancin - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...